Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular characterization of ESR1 variants in breast cancer.
Heeke AL, Elliott A, Feldman R, O'Connor HF, Pohlmann PR, Lynce F, Swain SM, Nunes MR, Magee D, Oberley MJ, Swenson J, Vidal G, Isaacs C, Schwartzberg L, Korn WM, Tan AR. Heeke AL, et al. Among authors: lynce f. Breast Cancer Res Treat. 2022 Nov;196(2):279-289. doi: 10.1007/s10549-022-06740-y. Epub 2022 Sep 20. Breast Cancer Res Treat. 2022. PMID: 36125660
First, do no harm.
Lynce F, Swain SM. Lynce F, et al. Onkologie. 2008 Oct;31(10):511-2. doi: 10.1159/000154472. Epub 2008 Sep 23. Onkologie. 2008. PMID: 18854649 Free article. No abstract available.
Avastin withdrawal symptoms.
Lynce F, Swain SM. Lynce F, et al. Expert Opin Pharmacother. 2012 Feb;13(3):293-8. doi: 10.1517/14656566.2012.652088. Epub 2012 Jan 21. Expert Opin Pharmacother. 2012. PMID: 22263961 No abstract available.
Pertuzumab for the treatment of breast cancer.
Lynce F, Swain SM. Lynce F, et al. Cancer Invest. 2014 Oct;32(8):430-8. doi: 10.3109/07357907.2014.922570. Epub 2014 Jun 12. Cancer Invest. 2014. PMID: 24921704 Review.
Deleterious BRCA1/2 mutations in an urban population of Black women.
Lynce F, Smith KL, Stein J, DeMarco T, Wang Y, Wang H, Fries M, Peshkin BN, Isaacs C. Lynce F, et al. Breast Cancer Res Treat. 2015 Aug;153(1):201-9. doi: 10.1007/s10549-015-3527-8. Epub 2015 Aug 7. Breast Cancer Res Treat. 2015. PMID: 26250392 Free PMC article.
Adaptive Randomization of Neratinib in Early Breast Cancer.
Park JW, Liu MC, Yee D, Yau C, van 't Veer LJ, Symmans WF, Paoloni M, Perlmutter J, Hylton NM, Hogarth M, DeMichele A, Buxton MB, Chien AJ, Wallace AM, Boughey JC, Haddad TC, Chui SY, Kemmer KA, Kaplan HG, Isaacs C, Nanda R, Tripathy D, Albain KS, Edmiston KK, Elias AD, Northfelt DW, Pusztai L, Moulder SL, Lang JE, Viscusi RK, Euhus DM, Haley BB, Khan QJ, Wood WC, Melisko M, Schwab R, Helsten T, Lyandres J, Davis SE, Hirst GL, Sanil A, Esserman LJ, Berry DA; I-SPY 2 Investigators. Park JW, et al. N Engl J Med. 2016 Jul 7;375(1):11-22. doi: 10.1056/NEJMoa1513750. N Engl J Med. 2016. PMID: 27406346 Free PMC article. Clinical Trial.
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
Rugo HS, Olopade OI, DeMichele A, Yau C, van 't Veer LJ, Buxton MB, Hogarth M, Hylton NM, Paoloni M, Perlmutter J, Symmans WF, Yee D, Chien AJ, Wallace AM, Kaplan HG, Boughey JC, Haddad TC, Albain KS, Liu MC, Isaacs C, Khan QJ, Lang JE, Viscusi RK, Pusztai L, Moulder SL, Chui SY, Kemmer KA, Elias AD, Edmiston KK, Euhus DM, Haley BB, Nanda R, Northfelt DW, Tripathy D, Wood WC, Ewing C, Schwab R, Lyandres J, Davis SE, Hirst GL, Sanil A, Berry DA, Esserman LJ; I-SPY 2 Investigators. Rugo HS, et al. N Engl J Med. 2016 Jul 7;375(1):23-34. doi: 10.1056/NEJMoa1513749. N Engl J Med. 2016. PMID: 27406347 Free PMC article. Clinical Trial.
77 results